www.aviditybiosciences.com Open in urlscan Pro
104.197.177.129  Public Scan

Form analysis
1 forms found in the DOM

GET https://www.aviditybiosciences.com/

<form role="search" method="get" class="search-form" action="https://www.aviditybiosciences.com/">
  <label>
    <span class="screen-reader-text">Search for:</span>
    <input type="search" class="search-field" placeholder="Search …" value="" name="s">
  </label>
  <input type="submit" class="search-submit" value="Search">
</form>

Text Content

Skip to main content
Avidity Biosciences
Open mobile menu

 * About
 * Platform
 * Pipeline
 * Patients
 * Investors
 * Contact
 * Careers

Search
Search for:

First participants in the Phase 1/2 MARINA™ trial dosed with AOC 1001 -

Learn More »


DELIVERING
ON THE RNA
REVOLUTION

Luke
living with DM1

Karin
living with DM1

Kristl & Zen
living with DM1


DELIVERING A NEW CLASS OF RNA THERAPEUTICS

At Avidity Biosciences, we are driven by our mission: to profoundly improve
people’s lives by revolutionizing a new class of targeted RNA therapeutics. We
are doing this by realizing the broad and disruptive potential of our Antibody
Oligonucleotide Conjugates (AOC™) platform. Beginning with our muscle disease
franchise, our programs tackle the root cause of disease. Our innovative
pipeline is set to advance and expand into additional cells and tissues,
allowing us to address unmet patient needs across a wide-range of therapeutic
areas.


PLATFORM


DELIVERING ON OUR VISION

We are delivering a new class of RNA therapeutics - AOCs - which combine the
specificity of monoclonal antibodies and the precision of oligonucleotides.
Through integrating these proven technologies, our AOC platform is able to
deliver to previously inaccessible tissue and cell types and more effectively
target the underlying genetic drivers of diseases. With an agile and diverse
team, we are advancing and expanding our pipeline programs to offer treatment
options for patients and their families.


PATIENTS

© 2023 Avidity Biosciences



EXPLORE

 * About
   * Overview
   * Management
   * Board of Directors
 * Platform
   * Overview
   * Publications
 * Pipeline
   * Overview
   * DM1
   * FSHD
   * DMD
   * Next Indications
   * Expanded Access
 * Patients
 * Investors
   * Overview
   * News, Events and Publications
     * News Releases
     * Events and Presentations
     * Publications
   * SEC Filings
   * Corporate Governance
     * Board of Directors
     * Committee Composition
     * Corporate Governance Documents
   * Stock Information
     * Stock Quote
     * Interactive Chart
     * Investment Calculator
     * Historical Stock Price
   * FAQs
   * Analyst Coverage
 * Contact
 * Careers

CONTACT

10578 Science Center Dr.
Suite 125
San Diego, CA 92121

info@aviditybio.com

Tel: 858-401-7900

FOLLOW



LEGAL

 * Terms of Use
 * Privacy Policy
 * Patents
 * PO Terms & Conditions

×


AVIDITY ANNOUNCEMENT VIDEO